# Regentis Biomaterials Ltd. (RGNT) Source: https://www.quantisnow.com/company/RGNT Generated: 2026-11-09T09:37:53.988Z - Ticker: RGNT - Exchange: AMEX - Sector: Health Care - Industry: Industrial Specialties - IPO year: 2025 - SEC CIK: 0001912966 ## Latest RGNT news and filings - 2026-10-13 10:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6743921) - 2026-10-12 13:00 UTC [Market Insight] [Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal](https://www.quantisnow.com/insight/regentis-biomaterials-reports-strong-surgeon-interest-in-gelrincr-at-8th-6743614) - 2026-10-09 20:05 UTC [Market Insight] [Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City](https://www.quantisnow.com/insight/regentis-biomaterials-to-present-at-the-2026-thinkequity-conference-on-6742809) - 2026-09-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-regentis-biomaterials-ltd-6723496) - 2026-09-18 14:15 UTC [IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/ibn-announces-latest-episode-of-the-biomedwire-podcast-featuring-dr-6720248) - 2026-09-17 20:30 UTC [SEC Form POS AM filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-regentis-biomaterials-ltd-6719355) - 2026-09-11 13:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6712631) - 2026-09-11 13:00 UTC [Market Insight] [Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/regentis-biomaterials-reports-first-half-2026-financial-results-and-provides-6712603) - 2026-08-13 15:00 UTC [SEC Form SCHEDULE 13G filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-regentis-biomaterials-ltd-6679788) - 2026-08-11 13:26 UTC [SEC Form S-8] [SEC Form S-8 filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-regentis-biomaterials-ltd-6675284) - 2026-07-20 13:12 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6642162) - 2026-07-20 13:00 UTC [Market Insight] [Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology](https://www.quantisnow.com/insight/regentis-receives-japanese-patent-allowance-strengthening-its-global-gelrinc-intellectual-6642108) - 2026-07-15 13:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6637915) - 2026-07-15 13:00 UTC [Market Insight] [Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch](https://www.quantisnow.com/insight/regentis-receives-european-regulatory-approval-for-new-gelrinc-manufacturing-process-6637833) - 2026-07-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-regentis-biomaterials-ltd-6635908) - 2026-07-13 21:07 UTC [SEC Form 4] [SEC Form 4 filed by Director Alpert Susan Phd Md](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-alpert-susan-phd-md-6635683) - 2026-07-13 21:07 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-regentis-biomaterials-ltd-6635682) - 2026-07-13 21:07 UTC [SEC Form 4] [SEC Form 4 filed by Director Ben-Elazar Pini](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ben-elazar-pini-6635680) - 2026-07-13 21:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Valentine Keith](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-valentine-keith-6635677) - 2026-07-13 21:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Dykan Jeff](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-dykan-jeff-6635675) - 2026-07-13 21:05 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Geller Ehud](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-geller-ehud-6635673) - 2026-07-13 21:01 UTC [SEC Form 4] [SEC Form 4 filed by Director Cohen-Arazi Efraim](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-cohen-arazi-efraim-6635665) - 2026-07-09 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6633191) - 2026-07-08 20:31 UTC [SEC Form F-1] [SEC Form F-1 filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-f-1-filed-by-regentis-biomaterials-ltd-6631717) - 2026-07-02 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6625736) - 2026-06-25 21:00 UTC [SEC Form D] [SEC Form D filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-d-filed-by-regentis-biomaterials-ltd-6616192) - 2026-06-18 21:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6609450) - 2026-06-18 01:05 UTC [Market Insight] [Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement](https://www.quantisnow.com/insight/regentis-biomaterials-announces-pricing-of-a-65-million-private-placement-6607650) - 2026-06-15 15:57 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6602251) - 2026-06-15 15:52 UTC [SEC Form RW filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-regentis-biomaterials-ltd-6602245) - 2026-06-09 13:27 UTC [SEC Form F-1] [Amendment: SEC Form F-1/A filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-f-1a-filed-by-regentis-biomaterials-ltd-6594859) - 2026-06-08 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6592809) - 2026-06-08 12:32 UTC [Market Insight] [Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate](https://www.quantisnow.com/insight/regentis-to-commence-european-surgeon-training-for-gelrinc-in-knee-6592733) - 2026-06-04 20:30 UTC [SEC Form 6-K] [Amendment: SEC Form 6-K/A filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-6-ka-filed-by-regentis-biomaterials-ltd-6589649) - 2026-05-29 19:23 UTC [SEC Form FWP] [SEC Form FWP filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-regentis-biomaterials-ltd-6578876) - 2026-05-28 20:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-regentis-biomaterials-ltd-6577580) - 2026-05-01 21:23 UTC [SEC Form F-1] [SEC Form F-1 filed by Regentis Biomaterials Ltd.](https://www.quantisnow.com/insight/sec-form-f-1-filed-by-regentis-biomaterials-ltd-6527482) - 2026-04-16 12:30 UTC [Market Insight] [Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon](https://www.quantisnow.com/insight/regentis-implements-strategy-for-commercial-deployment-of-gelrincr-in-europe-6502430) - 2026-03-30 21:29 UTC [SEC Form 3] [SEC Form 3 filed by new insider Reske Galit](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-reske-galit-6476684) - 2026-03-18 20:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Geller Ehud](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-geller-ehud-6458262) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RGNT - Earnings history: https://www.quantisnow.com/earnings/RGNT - Dividend history: https://www.quantisnow.com/dividends/RGNT - Insider transactions: https://www.quantisnow.com/insiders/RGNT - Options chain: https://www.quantisnow.com/options/RGNT - SEC 8-K filings only: https://www.quantisnow.com/company/RGNT/8-k - RSS and alerts for RGNT: https://www.quantisnow.com/docs/rss-feeds.md